Stanford researchers in the Lin Lab have identified kinase-modulated bioluminescent indicators (KiMBIs) which can assess real time kinase inhibition in target tissues in vivo.
Stanford scientists in Chris Garcia's lab have developed leptin analogs that have potentially more favorable pharmacokinetic and pharmacological signaling properties for use as diabetes and obesity drugs.
Stanford researchers at the Zare Lab, Department of Chemistry, have developed a simple and eco-friendly method that could potentially produce substantial amounts of ammonia and urea, both of which are primarily used in fertilizer.
Stanford researchers have developed a method to activate, cryopreserve, and thaw T regulatory (Tregs) cells that preserves their viability, phenotype and function.
Stanford researchers have developed a method to eliminate antibiotic resistant gram-negative bacteria in the growth arrest phase. The increase in relapsing bacterial infections and the rise of drug resistant bacteria are significant global health problems.
Active manipulation of light beams is required for a range of emerging optical technologies, including sensing, optical computing, virtual/augmented reality, dynamic holography, and computational imaging.
Wound healing is a huge clinical problem. Problematic outcomes of skin wounds can range from under-healing (e.g., chronic/non-healing wounds) to over-healing (e.g., scarring).
Stanford researchers have identified exercise-inducible, carboxylesterase 2 (CES2) proteins, which suppress obesity in high fat diet-fed mouse models. Generally, CES2 proteins are intracellular and localized to the endoplasmic reticulum.
Stanford scientists have developed broadly neutralizing antibodies against sarbecoviruses , including SARS-CoV-2 related Clade 1b, SARS-CoV related Clade 1a and Clade 3 viruses, paving the way for future vaccines and therapeutics.
Stanford inventors have devised a method of multiplexing droplet reactions to analyze and identify many reactions in parallel on a single microfluidic chip using off-the-shelf flow control and valving.
Researchers at Stanford University have developed a novel method for the first time to generate cardiac pericytes from human induced pluripotent stem cells that closely resemble primary cells.